Home  /  Resource Library  /  Romidepsin Plus CHOEP Falls Short in Newly Diagnosed Peripheral T-Cell Lymphoma

Romidepsin Plus CHOEP Falls Short in Newly Diagnosed Peripheral T-Cell Lymphoma

ASH 2021